IMD Startup Competition 2023/2024
THE 26TH EDITION OF THE IMD STARTUP COMPETITION IS NOW OPEN!
Seize your chance
Could your startup benefit from highly talented, experienced, and motivated individuals who have been carefully screened to participate in two of the most selective and rigorous business programs in the world?
If so, this competition provides you with a unique opportunity to get help and insights from participants in IMD’s MBA and Executive MBA programs.
This offer is open to all Swiss-based startups and runs in collaboration with the Swiss government’s Innosuisse-Swiss Innovation Agency, VentureKick, MassChallenge Switzerland, Verve, and Amazon Web Services.
We select up to 30 different startups to work with IMD MBAs and Executive MBAs.
We are looking for early-stage companies that have a solid chance of market success and have a curious team that is willing to open themselves up to a small group of management “students” and enter into both strategic and business model discussions to provide a valuable learning opportunity for our participants with timing that aligns with the IMD programs.
Grow your business, test your concepts, get new insights:
work with our MBA and EMBA participants
Many ventures got lasting value from working with our MBAs and EMBAs (as well as our BOT and Evonik participants). In the most recent Swiss Top 100 report, IMD-supported startups captured 31 of the 100 places, including two out of the top 10, and seven of the top 25 scale-ups. Do you want to be in that group next year?
As additional support for Swiss startups, and to help the Swiss entrepreneurial ecosystem, winners of the IMD Startup Competition will now receive a CHF 5,000 Startup Scholarship to be used to participate in any of IMD’s online or open programs.
And this year again, we’re pleased to announce that Amazon Web Services is partnering with us and will support the winners of the IMD Startup Competition: “From Airbnb to Zocdoc, the world’s top startups build on AWS. But they didn’t do it alone. So whether you need help solving a technical challenge, hiring the right engineers, or finalizing a fundraising round, AWS has all the resources you need to get started. There’s a reason more startups build on AWS than any other provider: AWS is there to help you succeed, from inception to IPO. With this partnership, the startups winning the IMD Startup Competition get access to the network of opportunities through AWS Startups.
Recent Winners of the Startup Competition
Executive MBA project opportunity
- Up to 10 or 12 startups will be chosen to work with two Executive MBA classes
- Split into small teams, each working with a dedicated startup, our EMBAs help analyze and challenge your business plans and company strategies
- Their ultimate goal is to make a pitch on your behalf to venture capitalists and angels in Silicon Valley in November (with the presence of your founders)
EMBA 1st Intake
(Feb 2025 graduating class)
EMBA 2nd Intake
(Sept 2025 graduating class)
At IMD Lausanne
Tuesday Sept 10*, 2024 pm
Friday Sept 13*, 2024 am
Tuesday Sept 23*, 2024 pm
Friday Sept 27*, 2024 am
In Palo Alto, California
November 10-15, 2024
November 17-22, 2024
*Subject to change
Meet with EMBAs @ IMD, Lausanne
Collaborate at a distance with EMBAs
Travel to Silicon Valley with the EMBAs
MBA project opportunity
- Up to 20 startups will receive the support of our MBA class
- Split into small teams, each working with a dedicated startup, our MBAs put in an average of 10-12 hours per person on this project each week, for a total support of at least 400-500 work-hours
January 22, 2024
MBA-selected companies meet with their MBA teams at IMD in Lausanne that evening
January 27, 2024
In-company introductory visits for MBA participants at the company's site (wherever possible or desirable)
January 22 - March 11, 2024
MBA-selected companies collaborate with their MBA teams
Meet with MBAs @ IMD, Lausanne
Face-to-face & virtual collaboration
Mutually agreed upon project
FDA Clearance for SmartCardia ECG 7L Patch and Cloud Platform
SmartCardia, the Swiss medtech based at EPFL Innovation Park, has received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud platform. SmartCardia’s 7L patch is easy-to-wear, cable-free, waterproof and can be used for continuous monitoring for up to 14 days.
FIT funding for Neology and ClearSky
Neology is driving the evolution of carbon-free mobility by leveraging the potential of ammonia, while ClearSky is revolutionizing AI assistants by focusing on privacy protection. Awarded by the Foundation for Technological Innovation (FIT), the Tech Seed loans of CHF 100,000 each will boost these start-ups to the next level in their technological development.
Withings equips its latest smartwatch with greenteg technology
The latest Withings consumer hybrid wristwatch, the ScanWatch 2 features a new sensor that allows users to track core body temperature continuously 24/7. This technology comes from ETH Zurich spinoff greenteg, provider of sensors for wearables and medtech applications.
Haelixa receives a new capital injection from Zürich Silk Association
Haelixa provides next-generation solutions for transparency in consumer goods supply chains. The capital from the Zurich Silk Association (ZISG), one of Switzerland’s oldest trade groups, will support the scale of Haelixa’s global operations
Koa enters a new era with Africa’s largest cocoa fruit factory
The Ghanaian-Swiss start-up has officially opened its second cocoa fruit factory in Akim Achiase, in the Eastern Region of Ghana. The new facility will allow Koa to scale its production capabilities tenfold and thereby allowing the company to cooperate with an additional 10,000 cocoa smallholders in Ghana.
World first medical device implantation to restore erectile function
A world first implantation of a high-tech, battery-powered device to restore erectile function, has taken place at the Royal Melbourne Hospital (RMH) leading a global trial. Comphya’s CaverSTIM is the first implantable ‘neurostimulator’ for erectile dysfunction treatment, designed for patients that are non-responders to oral drugs, including spinal cord-injured patients and post-prostatectomy patients.
ZuriMED closes CHF 14.5 million Series A round
Leading healthcare investors have contributed CHF 14.5 million to ZuriMed Technologies’ Series A investment round. The capital will enable ZuriMed to accelerate the development and market entry of its Surgical-Fiberlock technology for minimally invasive surgical repair of soft tissues.